NCT06900855 is a clinical trial in Demographic Profiles, sponsored by Assiut University.

Who is sponsoring NCT06900855?

NCT06900855 is sponsored by Assiut University.

What condition does NCT06900855 study?

NCT06900855 studies Demographic Profiles, Impairment Certificates, Visual Impairment.

Is NCT06900855 still recruiting?

NCT06900855 is currently not yet recruiting. Last updated 28 March 2025.

Last reviewed 2025-03-28 · How we verify

NCT06900855

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patients Seeking a Visual Impairment Certificate

Not yet recruiting Last updated 28 March 2025

What this trial tests

trial in Demographic Profiles in 383 participants. Not yet recruiting.

Timeline

1 May 2025

Primary endpoint
30 December 2025

30 August 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	383
Start date	1 May 2025
Primary completion	30 December 2025
Estimated completion	30 August 2026

Conditions studied

Demographic Profiles — all drugs for Demographic Profiles →
Impairment Certificates — all drugs for Impairment Certificates →
Visual Impairment — all drugs for Visual Impairment →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Demographic Profiles or Impairment Certificates. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the prevalence, causes, and demographic characteristics of patients seeking visual impairment certificates at Assiut Ophthalmology Hospital. Using a prospective cross-sectional design, it aims to identify the magnitude and nature of visual impairment in this population by analyzing clinical data, performing comprehensive eye examinations, and utilizing advanced diagnostic tools.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06900855 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 28 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06900855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing